December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Roberto Iacovelli: Insights into the use of tumor tissue or ctDNA-based testing at ESMO Asia24
Dec 8, 2024, 23:45

Roberto Iacovelli: Insights into the use of tumor tissue or ctDNA-based testing at ESMO Asia24

Roberto Iacovelli, Medical Oncologist at Gemelli Polyclinic Foundation IRCCS, shared a post on X:

“Elena Castro gave us valuable insights into the use of tumor tissue or ctDNA-based testing at ESMO Asia24. Regarding genes, BRCA1/2 is the minimum but need to be ready for HRR and PTEN.”

Roberto Iacovelli: Insights into the use of tumor tissue or ctDNA-based testing at ESMO Asia24

More posts featuring Roberto Iacovelli.

Dr. Roberto Iacovelli, is a medical oncologist at Gemelli Polyclinic Foundation IRCCS in Rome, Italy. With a focus on genitourinary cancers, his research focuses on metastatic renal cell carcinoma, prostate, and bladder cancer, exploring predictive factors and therapy sequencing.

Dr. Iacovelli’s contributions include over 150 publications in peer-reviewed journals and numerous awards for his work, including the ASCO Cancer Foundation Merit Award in 2011.